Wlazeł, R.N.; Guligowska, A.; Chrząstek, Z.; Kostka, T.; Jegier, A.; Szadkowska, I.
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Is a Biomarker Associated with Left Ventricular Hypertrophy in the Elderly, Specifically in Women. J. Clin. Med. 2023, 12, 3290.
https://doi.org/10.3390/jcm12093290
AMA Style
Wlazeł RN, Guligowska A, Chrząstek Z, Kostka T, Jegier A, Szadkowska I.
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Is a Biomarker Associated with Left Ventricular Hypertrophy in the Elderly, Specifically in Women. Journal of Clinical Medicine. 2023; 12(9):3290.
https://doi.org/10.3390/jcm12093290
Chicago/Turabian Style
Wlazeł, Rafał Nikodem, Agnieszka Guligowska, Zuzanna Chrząstek, Tomasz Kostka, Anna Jegier, and Iwona Szadkowska.
2023. "Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Is a Biomarker Associated with Left Ventricular Hypertrophy in the Elderly, Specifically in Women" Journal of Clinical Medicine 12, no. 9: 3290.
https://doi.org/10.3390/jcm12093290
APA Style
Wlazeł, R. N., Guligowska, A., Chrząstek, Z., Kostka, T., Jegier, A., & Szadkowska, I.
(2023). Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Is a Biomarker Associated with Left Ventricular Hypertrophy in the Elderly, Specifically in Women. Journal of Clinical Medicine, 12(9), 3290.
https://doi.org/10.3390/jcm12093290
